Commentary

They're closing the gap with in terms of earning, but not in terms of investable assets.

Today, leave sits at the intersection of regulatory expansion, workforce expectations, and enterprise risk, carrying real financial implications.

Employers need a durable framework for evaluating new medical innovations, anchored by advanced primary care and direct care contracting.

Unbundled pharmacy benefit services put employers in control

The author has a four-step plan for employers that want to build strong vaccination outreach programs.

Novo Nordisk believes that by marketing such untested medicines, Hims & Hers is exposing patients to drugs that may contain dangerous impurities or incorrect amounts of active ingredients, resulting in life-jeopardizing immune reactions.